Global Diseases Research

                                                                       A newly observed COVID-19 variant, BA.3.2—commonly referred to as “Cicada”—is gradually increasing in detection across several regions worldwide. Health authorities indicate that the variant had been circulating at low levels for an extended period before its recent rise in visibility. Its name reflects this prolonged hidden presence, similar to cicadas that remain underground for years before emerging. Origins and Detection Timeline The earliest known case of BA.3.2 was recorded in South Africa in November 2024. The variant began showing a noticeable increase in spread from September 2025. In the United States , it was initially identified in a traveller in mid-2025, with broader reporting beginning in early 2026. It has now been detected...

  A recent development in global healthcare has brought attention to Lyme disease, as pharmaceutical companies Pfizer and Valneva announced that their experimental vaccine demonstrated over 70% efficacy in late-stage clinical trials. This progress offers hope in combating a disease that is increasingly reported across multiple regions. About Lyme Disease Lyme disease, also known as Lyme borreliosis, is a bacterial infection caused by “Borrelia burgdorferi”. It affects multiple systems in the body, including the skin, joints, heart, and nervous system. The disease was first identified in 1976 in Lyme, Connecticut, United States , from which it derives its name. It is most commonly found in North America, Europe , and parts of Asia . Transmission and Spread Lyme disease is transmitted to humans through the bite of infected deer ticks, also known as black-legged ticks. These ticks are typically found in grassy, wooded, and bushy environments and can attach to the human body without im...

The Best Malaria Research Scientist Award is a prestigious honor under the Global Diseases Research Awards, recognizing outstanding scientists who have made significant contributions to malaria research. This award highlights excellence in areas such as vaccine development, parasite biology, epidemiology, and innovative vector control strategies aimed at global malaria eradication . Event Details: Website: globaldiseases.org Nomination Link: https://globaldiseases.org/award-nomi.. . To Contact: support@globaldiseases.org Nominate now and celebrate the Best Malaria Research Scientist Award #VaccineDevelopment #GlobalHealth #MedicalInnovation #DiseasePrevention #PublicHealth #GlobalDiseases #ResearchExcellence #ScientificAchievement #HealthcareInnovation #GlobalDiseasesResearchAwards  

  In a significant milestone for rare disease treatment, the United States Food and Drug Administration has approved Zycubo (copper histidinate) for the treatment of paediatric patients with Menkes disease. The approval marks the first and only authorised therapy for the condition in the United States, offering new hope for affected children and their families. Regulatory Approval and Company Background Zycubo has been approved for use in children suffering from Menkes disease, a rare and often fatal genetic disorder. The therapy has been developed by Sentynl Therapeutics Inc, which is wholly owned by Zydus Lifesciences. Sentynl acquired the drug from Cyprium Therapeutics in 2023 and subsequently advanced it through the final stages of regulatory review with the U.S. Food and Drug Administration. Clinical Development and Special Designations The approval was supported by positive results from pivotal clinical studies. During development, Zycubo received multiple regulatory designat...

  The Outstanding Vaccine Development Award in the Global Diseases Research Awards honors researchers and scientists who have made exceptional contributions to vaccine innovation and development. This award recognizes groundbreaking work that advances prevention, control, and eradication of global infectious diseases, improving public health and saving lives worldwide. Event Details: Website: globaldiseases.org Nomination Link: https://globaldiseases.org/award-nomi... To Contact: support@globaldiseases.org Nominate now and celebrate the Outstanding Vaccine Development Award #VaccineDevelopment #GlobalHealth #MedicalInnovation #DiseasePrevention #PublicHealth #GlobalDiseases #ResearchExcellence #ScientificAchievement #HealthcareInnovation #GlobalDiseasesResearchAwards

  The Excellence in Tropical Medicine Research category at the Global Diseases Research Awards honors outstanding scientists and healthcare professionals who have made significant contributions to the understanding, prevention, diagnosis, and treatment of tropical and neglected diseases. This award recognizes impactful research addressing malaria, dengue, tuberculosis, parasitic infections, and other emerging or re-emerging infectious diseases that disproportionately affect low- and middle-income countries.  Event Details:  Website: globaldiseases.org  Nomination Link: https://globaldiseases.org/award-nomi.. .  To Contact: support@globaldiseases.org  Nominate now and celebrate the Excellence in Tropical Medicine Research #TropicalMedicine #GlobalHealth #InfectiousDiseases #NeglectedTropicalDiseases #MedicalResearch #PublicHealth #DiseasePrevention #GlobalDiseasesResearchAwards